Back to search results

Fluid-Guided Heart Failure Treatment at Cleveland Clinic

This study, called FIGHT-HF, is looking at a new way to manage heart failure using a special device called the Bodyport Cardiac Scale. This scale helps you and your doctor track your weight and fluid levels. Your doctor will also get alerts and a dashboard to help them manage your care remotely. The study aims to see how well this system works in 50 adults who have been hospitalized for acute decompensated heart failure (a sudden worsening of heart failure symptoms). To join, you must be at least 21, able to speak and read English, and not have severe heart failure symptoms or be scheduled for a heart transplant soon. The main goal is to see how often the system generates alerts about congestion (fluid buildup) over 90 days.

Study design
This is an exploratory, non-randomized, open-label study involving 50 participants. It is evaluating a heart failure management intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your progress will be monitored from enrollment until the end of the study duration at 90 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07205120

Fluid Guided Heart Failure Treatment at the Cleveland Clinic

Recruiting
NAAges 21+InterventionalTreatment
Bodyport Inc.
~50 participants
Updated 2025-11-12 on ClinicalTrials.gov
What's tested:Heart Failure Management Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Congestion Index Alert Statistics
Measured over From enrollment to the end of the study duration at 90 days

Conditions

Heart Failure

Explore related trials

Heart Failure

NCT07205120

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • The Cleveland Clinic

    Cleveland, Ohiostudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Elaine Franko
[email protected]
216-444-9020
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Hospitalized for acute decompensated heart failure
Age 21 years or older
Able to speak and read English

Exclusion

New York Heart Association functional class IV symptoms
Received or are scheduled to receive a heart transplant or ventricular assist - device in the next 12 months
Have a glomerular filtration rate of less than 25 mL/min while nonresponsive to diuretic therapy or on chronic renal dialysis
Have a history of regularly scheduled intravenous HF therapy (e.g., inotropes or diuretics)
Have a life expectancy of less than 12 months
Are pregnant or plan to become pregnant during the next 12 months
Weigh greater than 375 lbs
Unable to stand on two bare feet without assistance

What this trial measures

  • Congestion Index Alert StatisticsFrom enrollment to the end of the study duration at 90 days